Promising Small Cap Stocks To Watch Today – November 4th

Ohmyhome, Array Technologies, AltC Acquisition, Nurix Therapeutics, and Shoals Technologies Group are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations, typically ranking below large- and mid-cap companies, though the exact size range varies by index or market. They may offer greater growth potential but often carry higher volatility, lower liquidity, and greater business risk than larger companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Ohmyhome (OMH)

Ohmyhome Limited operates as a data and technology-driven property technology company in Singapore and Malaysia. It offers brokerage services that allows customers to purchase, sell, rent, or lease their properties on its platform. The company also offers other property-related services, including listing and research services comprising online property listings, property transaction guides, automated electronic valuation of listed properties, and calculators; mortgage advice and financing guidance services; and legal services, such as conveyancing, legal advice, and documentation preparation services.

Shares of OMH stock traded up $2.82 during mid-day trading on Wednesday, reaching $5.74. The stock had a trading volume of 63,562,720 shares, compared to its average volume of 513,334. Ohmyhome has a 12-month low of $2.05 and a 12-month high of $109.50. The business has a 50-day simple moving average of $2.83 and a 200 day simple moving average of $33.61.

Array Technologies (ARRY)

Array Technologies, Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects in the United States, Spain, Brazil, Australia, and internationally. The company operates in two segments, Array Legacy Operations and STI Operations. Its products portfolio includes DuraTrack HZ v3, a single axis tracker; Array STI H250 that delivers a lower levelized cost of energy with tracker system; Array OmniTrack; and SmarTrack, a software product that uses site-specific historical weather and energy production data in combination with machine learning algorithms to identify the optimal position for a solar array in real time to enhance energy production.

Shares of Array Technologies stock traded up $0.68 during trading on Wednesday, hitting $5.32. 48,470,367 shares of the company were exchanged, compared to its average volume of 6,565,364. Array Technologies has a fifty-two week low of $3.09 and a fifty-two week high of $12.23. The stock has a market capitalization of $818.56 million, a price-to-earnings ratio of -5.46, a P/E/G ratio of 0.88 and a beta of 1.81. The firm has a 50 day moving average price of $3.98 and a 200 day moving average price of $6.87.

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Shares of NYSE:ALCC traded down $0.03 during midday trading on Wednesday, reaching $23.49. The company’s stock had a trading volume of 10,859,090 shares, compared to its average volume of 723,393. AltC Acquisition has a 1 year low of $10.27 and a 1 year high of $18.80. The business has a 50 day moving average price of $35.16 and a 200 day moving average price of $53.72.

Nurix Therapeutics (NRIX)

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications.

Shares of NASDAQ NRIX traded down $9.56 during midday trading on Wednesday, hitting $16.26. The stock had a trading volume of 14,622,622 shares, compared to its average volume of 1,651,818. Nurix Therapeutics has a 1-year low of $11.67 and a 1-year high of $28.23. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of 7.04 and a beta of 1.80. The company has a fifty day moving average price of $24.95 and a 200 day moving average price of $20.27.

Shoals Technologies Group (SHLS)

Shoals Technologies Group, Inc. provides electrical balance of system (EBOS) solutions and components for solar, battery energy, and electric vehicle (EV) charging applications in the United States and internationally. The company designs, manufactures, and sells system solutions for both homerun and combine-as-you-go wiring architectures, as well as offers technical support services.

SHLS stock traded up $0.46 during midday trading on Wednesday, hitting $8.93. 22,557,529 shares of the company’s stock were exchanged, compared to its average volume of 5,246,386. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of 47.52, a price-to-earnings-growth ratio of 0.91 and a beta of 1.86. The firm has a 50 day moving average price of $7.60 and a 200-day moving average price of $8.47. The company has a current ratio of 2.25, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. Shoals Technologies Group has a 12-month low of $5.43 and a 12-month high of $13.18.